A prospective, randomized, double-blind, parallel, placebo-controlled, multicenter clinical study of acupoint application in the treatment of endometriosis

Phase 1

• Conditions: Endometriosis

• Registration Number: ITMCTR2200005686
• Lead Sponsor: Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

1. Meet the diagnostic criteria of endometriosis;

2. Age 18-45, menstrual cycle 21-35 days, period 3-7 days;

3. Patients with mass diameter < 4 cm;

4.35IU/L < serum CA125 < 80IU/L;

5. Informed consent and signing of informed consent.

Exclusion Criteria

1. Dysmenorrhea caused by various primary dysmenorrhea or other diseases;

2. Have accepted other new drug clinical experimenter in recent 3 months;

3. People with coagulation disorder;

4. People who have been allergic to multiple drugs or have an allergic constitution;

5. Persons with combined mental illness, alcoholism and/or psychoactive substance substance abuse and dependence;

6. Patients with skin trauma, ulcers, skin infection or scar at the application site and those who are allergic to the patch;

7. Pregnant or lactating women.

Note: any one or more of the above items should be excluded and cannot be selected.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
terine size, mass size;Dysmenorrhea symptom score;CA125;Dysmenorrhea pain score;